How to Get Free Help Choosing a Medicare Part D Prescription Drug Plan in 2027

How to Get Free Help Choosing a Medicare Part D Prescription Drug Plan in 2027
Learn where to get free, unbiased help choosing a 2027 Medicare Part D plan, from SHIP counselors to Plan Finder, plus a drug-by-drug checklist to use first.

Key Points

  • Medicare's 2027 Part D plans carry a $2,400 yearly cap on covered drug costs and a $700 standard deductible, up from the 2026 limits of $2,100 and $615.
  • KFF estimates the average monthly premium for a stand-alone drug plan rises from $34 in 2026 to $51 in 2027 for people who stay in their current plans.
  • SHIP counselors are government funded and give free, unbiased Part D plan comparisons; call 877-839-2675 and say "Medicare" when prompted to find your local SHIP.
Three things people choosing a Part D plan believe. Myth or fact?
Call each one, then see how other readers called it.
1 If a drug is on a plan's list, you can fill it with no extra steps.
2 The same drug can cost more at one pharmacy than another under the same plan.
3 Some Part D prescriptions have to reach the pharmacy electronically.
How to Get Free Help Choosing a Medicare Part D Prescription Drug Plan in 2027

Short answer: How to Get Free Help Choosing a Medicare Part D Prescription Drug Plan in 2027 is a Medicare care-navigation topic and refers to the practical steps explained in this guide. Learn where to get free, unbiased help choosing a 2027 Medicare Part D plan, from SHIP counselors to Plan Finder, plus a drug-by-drug checklist to use first. Understood Care advocates have helped thousands of members with how to get free. Compared to generic medical helplines, our advocates work one-to-one across 50 states.

Quick Answer

Free, unbiased help choosing a 2027 Part D plan comes from your State Health Insurance Assistance Program (SHIP), Medicare Plan Finder on medicare.gov and 1-800-MEDICARE. Bring each drug's exact dose and your pharmacies.

Compare total yearly cost, not the premium alone. Check every drug for approval or step rules. Licensed brokers can help too, though plans pay them. An Ohio State University effort to measure how well people pick these plans was withdrawn before enrolling anyone, so I'd lean on a second set of eyes before December 7.

Did this answer your question?
Photorealistic editorial photo of an older woman with reading glasses seated at a sunlit kitchen table in soft morning light, a mug of tea beside her, one hand resting on her chin as she studies a neat row of amber pill

Checking each prescription, one by one, against the plans you are considering for 2027.

It's common to feel buried in Part D information this time of year and still have no idea which plan fits you. Mailers pile up. The phone rings. Every plan claims to be the right one.

One thing surprised me while gathering research for this guide. There is no clean measure of how well people choose these plans. An Ohio State University study, registered on ClinicalTrials.gov in 2014, set out to find what share of Part D enrollees were in their ideal plan based on estimated costs. It was withdrawn with 0 participants enrolled, so it never produced an answer.

That leaves the checking to you and to whoever you ask for help. That is no reason to worry. It is a reason to go one step at a time, with the right people beside you.

Below, you will find what changes for 2027 and what a plan can quietly change when it renews. You will see who gives unbiased help, including SHIP counselors, Medicare Plan Finder, 1-800-MEDICARE, licensed brokers and enrollment navigators, along with how each one is paid. There is also a drug-by-drug checklist you can carry to any of them, plus answers on Extra Help and late penalties.

And if a call about your drug plan starts to sound more like a sales pitch than help, you have somewhere to turn. Senior Medicare Patrol takes reports of suspected Medicare fraud, errors or abuse at 877-808-2468.

If a pile of plan mailers is sitting on your kitchen table and you are not sure where to start, you are not alone. Choosing a drug plan can feel like a test nobody prepared you for. It isn't one. Unbiased help with Medicare Part D already exists, and much of it is free: a trained SHIP counselor, Medicare's own Plan Finder and the 1-800-MEDICARE line can all walk you through your choices without selling you anything.

That help matters more this year. The yearly limit on what you pay for covered drugs is tied to growth in drug spending, so it moves every year. Recent research on Part D drug lists also found that in 2026, the first year of negotiated drug prices, what people paid at the pharmacy did not change. A SHIP counselor can price your exact drugs under several plans in one sitting, which is hard to do alone at the kitchen table.

Bring your pill bottles to that call. I'd rather you see those rules now, while you can still switch, than at the pharmacy counter in January. So it can help to start with your own medication list, one drug at a time.

Not sure how your drugs will fare in a 2027 plan?

A higher yearly cap, step rules returning on some negotiated drugs, and Extra Help limits that SHIP counselors say are not the whole story can all shift your numbers. An Understood Care advocate, covered by Medicare, can go through your medication list with you. Call 646-904-4027 to talk with an advocate.

What changes for Part D in 2027?

Medicare's 2027 Part D plans carry a $2,400 yearly cap on covered drug costs and a $700 standard deductible, both higher than the 2026 limits of $2,100 and $615.

Before you look at a single plan, it can help to run through four quick checks:

  1. Find your plan's Annual Notice of Change in your mail and read the drug list section first.
  2. Write down every medicine you take, with the dose.
  3. Note which of those drugs your plan restricts today.
  4. Decide whether your current pharmacy matters to you, or whether you could switch.

The Centers for Medicare & Medicaid Services set the 2026 out-of-pocket threshold at $2,100, which was the 2025 cap of $2,000 adjusted for growth in drug spending. For 2027, Medicare has announced the cap rises to $2,400 and the most a standard plan can charge as a deductible rises to $700. Your monthly premium does not count toward that cap. Translation: the cap protects you from big pharmacy bills, but you still pay premiums all year.

Here is the thing many people miss. The cap is tied to drug spending, so it moves every year. Last year's plan math will not hold for 2027.

The rules about which drugs you can actually get are shifting too. The common assumption is that a drug every plan covers is a drug you can easily fill. A 2026 study by Jain and McCoy in Health Affairs Scholar found that all 10 first-round negotiated drugs were covered by every Part D plan by 2026, yet plans could still add prior authorization (the plan must approve the drug first), step therapy (you try a cheaper drug first) and quantity limits. Step therapy on negotiated diabetes medicines rose to 5.0% in 2026, and on negotiated blood thinners to 4.8%. If you are not sure whether a new rule touches one of your drugs, you can ask the plan's member services line to check it by name and strength before you decide.

The longer trend points the same way. In 2024, Joyce and colleagues reported in Health Affairs that Part D plans restricted 31.9% of non-protected-class drugs in 2011 and 44.4% in 2020. Those numbers stop at 2020, so they cannot tell us exactly where restrictions stand today. That gap is real, and it is one reason I would never rely on last year's formulary.

A comparison of 5 sources shows one pattern: costs and rules are both moving, and they move every year. Federal rules are also still being written, including the drug inflation rebate program created under the Inflation Reduction Act of 2022. In practice, a plan that fit well in 2026 may quietly stop fitting in 2027.

Drug costs rarely arrive alone. One of our Understood Care advocates in Florida recently helped a patient set up an installment plan that stopped her electric service from being shut off. Prescription bills sit right next to utility bills in a household budget, which is why I encourage families to look at how Medicare patient advocates compare before a pharmacy bill and a past-due notice land in the same week.

So the next question is who can sit down with you and run these numbers for your own drugs.

What could you miss if you let your drug plan renew for 2027?

In short: Do nothing this fall, and one estimate says the average stand-alone drug plan premium jumps by half.

Do nothing this fall, and one estimate says the average stand-alone drug plan premium jumps by half. Even so, the premium is the easiest of several 2027 cost changes to spot.

The estimate comes from KFF, the health policy research organization, which published its analysis of CMS plan data on October 30, 2026. We read it in a summary written for Medicare insurance agents. If people stay in their current plans, the enrollment-weighted average monthly premium for a stand-alone drug plan goes from $34 in 2026 to $51 in 2027. About 76% of stand-alone enrollees without Extra Help, roughly 10.4 million people, would pay more each month. Zero-premium stand-alone plans are gone, and about 4.1 million people without Extra Help who have one now will see an increase if they stay. A CMS demonstration that supported participating stand-alone plans and limited some premium increases ends after 2026.

CMS projects a much smaller change. An insurance agency's 2027 guide reports the CMS stand-alone average moving from $35.09 to approximately $36. KFF modeled people who stay put, and a market average can come out lower when people switch to cheaper coverage. If you plan to let your coverage renew, KFF's scenario is the one that describes you.

The agents' summary also warned of unexpected prescription costs "even when their monthly premiums appear affordable." KFF's estimates show where those costs come from.

2027, KFF estimatesStand-alone drug plansMedicare Advantage drug plans
Enrollees in plans that charge a deductible99.8%85%
Median coinsurance, preferred brand25%20%
Median coinsurance, non-preferred drugs35%29%
Median coinsurance, specialty drugs25%26%

The drug list is the second place people get caught out, because seeing your drug on it does not tell you how easily you can get it. In Health Affairs, researchers Geoffrey Joyce, Barbara Blaylock, Jiahua Chen and Karen Van Nuys traced a decade of rising Part D restrictions. By 2020 the average formulary left out 44.7% of brand-name-only drugs, and stand-alone plans restricted more than Medicare Advantage drug plans. The authors grant that these tools can keep prescribing cost-effective. They also warn the tools can "reduce adherence and harm patient health."

Research from October 2026 shows how narrowly those rules can land. The Inflation Reduction Act requires every plan to cover the drugs chosen for Medicare price negotiation, and by 2026 all 10 first-round drugs were on every plan. Researchers V. Jain and R.G. McCoy studied formulary files from 2019 to 2026. They found step therapy on the negotiated diabetes drugs fell to zero by 2025, then rose to 5.0% of enrollment-weighted coverage in 2026, while similar drugs that were not negotiated stayed below 1%. A companion study found most of the increase was on one drug.

Empagliflozin, 2025 0.00%
Empagliflozin, 2026, first year of its negotiated price 18.18%
Dapagliflozin, 2026, also price-negotiated 1.21%
Same drug class, same negotiation, different rules. Entry-level step therapy rates on Medicare Part D formularies, from Jain and McCoy in Endocrine, October 2026.

The researchers are careful about how far this goes. At least 98% of formularies offered a drug in this class without prior authorization, and they concluded that restrictions "do not appear to be a major barrier" for the class as a whole. Their point is narrower. A drug's class, or how it was treated last year, does not tell you how a plan will treat your exact drug.

"Guaranteed coverage does not guarantee access."

Jain and McCoy, study authors, Health Affairs Scholar, 2026

Their study found something else people on negotiated drugs may not expect. In 2026, what people paid at the pharmacy did not change, because cost sharing is set by formulary tier. Fifteen more drugs, including Ozempic, Rybelsus and Wegovy, get negotiated prices on January 1, 2027. If 2026 is any guide, a lower Medicare price does not guarantee a lower copay.

Plan Finder can bring all of this together by ranking plans on total yearly cost, which combines the premium and drug costs. A benefits agency demonstrating the 2027 tool showed that one drug's price can change from pharmacy to pharmacy within a single plan. In the presenter's words, the result is "as accurate as the information you give it."

Looked at side by side, the 2027 changes have something in common. A renewal notice puts the premium in front of you. Everything else depends on your individual prescriptions: a deductible nearly every stand-alone enrollee will face, coinsurance set by tier, and a step rule that can apply to one drug and skip a close relative. A plan can look cheap and list every drug you take, yet still cost you more or slow down a refill.

Before open enrollment closes on December 7, 2026

  1. Before letting your plan renew, compare it with other plans in Plan Finder sorted by total yearly cost. KFF's steep estimate describes people who stay put.
  2. For each brand-name drug, ask which tier it sits on, what coinsurance that tier carries, and what you will pay until the deductible is met.
  3. Ask whether each drug carries step therapy, prior authorization or a quantity limit for 2027, even if it had none on your 2026 plan.
  4. If you take a drug with a new negotiated price, ask a SHIP counselor or the plan what your 2027 copay will be. Do not assume it drops with the price.
  5. Enter every drug with its exact strength, and every pharmacy you might use, before you trust a Plan Finder ranking.

How we checked this

We drew on three peer-reviewed studies of Part D formularies, a KFF analysis of 2027 premiums and cost sharing, a CMS premium projection and a demonstration of the 2027 Plan Finder. None of the figures here are ours. We read KFF's findings in a summary by a firm that supports Medicare insurance agents, and the CMS projection in an insurance agency's guide. We did not read either original directly. Agencies and agent support firms earn money when people enroll in plans. We offer care navigation and advocacy, so we also have a stake in people looking for help. KFF's increase assumes nobody switches plans. The 2011 to 2020 study leaves out protected-class drugs. The step therapy figures cover diabetes and related drugs, and the newer studies looked at 9 of the 10 first-round negotiated drugs. Still unknown: how plans will place and restrict the 15 drugs negotiated for 2027.

  1. KFF analysis as summarized by PSM Brokerage, 2027 Part D costs summary for agents, November 3, 2026.
  2. CMS stand-alone premium projection and the 2027 negotiated drug list, as reported in an insurance agency's guide to 2027 Medicare changes, September 23, 2026.
  3. Joyce, Blaylock, Chen and Van Nuys, Health Affairs, study of Part D utilization restrictions, 2011 to 2020, March 2024.
  4. Jain and McCoy, Health Affairs Scholar, study of restrictions on negotiated Part D drugs, October 2026.
  5. Jain and McCoy, Endocrine, study of SGLT2 inhibitor formulary access, October 2026.
  6. A benefits agency's video walkthrough of the 2027 Medicare Plan Finder, October 15, 2026.

Who offers free, unbiased help choosing a Part D plan?

In short: Who offers free, unbiased help choosing a Part D plan?: Your State Health Insurance Assistance Program, Medicare Plan Finder on medicare.

Your State Health Insurance Assistance Program, Medicare Plan Finder on medicare.gov and 1-800-MEDICARE all help at no charge. Of these, only SHIP gives you a trained person with nothing to sell.

It's common to feel wary when someone offers to "help" with Medicare. That instinct is healthy. The good news is that real, no-charge help exists, and you can tell the options apart by asking one question: who pays this person?

The national SHIP network explains that its counselors are government funded to give trusted, unbiased Medicare counseling, and the counseling is free. To find your local SHIP, call 877-839-2675 and say "Medicare" when prompted. SHIPs go by different names in different states. In New York, the program is called HIICAP, and a guide from Senior Directory NYC lists its statewide helpline as 1-800-701-0501. HIICAP counselors help with Part D drug plans, Medicare Advantage, Medigap, Extra Help and billing problems, in person or by phone.

That same guide offers a blunt warning I appreciate. "Many people who call themselves 'Medicare advisors' are paid by insurance companies when you sign up." Licensed brokers can be useful, but they are paid by the plans they sell. Some only represent a handful of insurers.

Type of helpWho pays themWhat they do wellWhat to watch for
SHIP counselorGovernment fundingUnbiased plan comparisons, Extra Help screening, billing questionsBusy during the fall enrollment window
Medicare Plan FinderRun by MedicareCompares plans by your drugs, pharmacies and ZIP codeOnly as accurate as what you type in
1-800-MEDICARERun by MedicareCoverage questions and enrollment, 24/7 except some federal holidaysPhone only, no ongoing case help
Licensed brokerInsurance companies, when you enrollWalks you through enrollmentMay show only plans they are contracted to sell
Enrollment navigator or benefits advisorVaries: employer, nonprofit or insurerCan help with forms and deadlinesAsk directly how they are paid

You can reach 1-800-MEDICARE at 1-800-633-4227 (TTY 1-877-486-2048). The Medicare Rights Center, a national nonprofit, runs a separate helpline at 800-333-4114.

One small detail is worth knowing. Medicare publishes a directory of drug plan contacts, but the plans themselves supply that contact information. Medicare does not verify it. So a phone number from a plan's own page is the plan talking, not Medicare.

Help also varies by where you live. Counseling capacity and plan choices differ from state to state, and it can be useful to see how many people are enrolled in Medicare where you live before you call. A crowded state often means a busy SHIP line in November.

My suggestion is gentle but firm: start with the free, unbiased option. Then, if you still want a broker, you will already know what a fair comparison looks like. The tool every one of these helpers uses is the same one you can open at home tonight.

What should you check for each medication before you pick a plan?

In short: Check each drug's exact name and dose, whether the plan covers it, any approval or step rules, its tier, and its price at your own pharmacy.

Check each drug's exact name and dose, whether the plan covers it, any approval or step rules, its tier, and its price at your own pharmacy. Then compare total yearly cost.

It's common to feel rushed this time of year. Loyola University Chicago's human resources office explains that the Medicare Annual Enrollment Period runs each year from October 15 through December 7, and it notes that "there may be some plan change restrictions during this enrollment period." That leaves you a few weeks, not a few days. You can work through this at your own pace.

Here is a checklist you can bring to Plan Finder, a SHIP counselor or an advocate. Take it one medication at a time.

  1. Write down the exact drug name and the correct milligrams. Plan Finder uses the dose to price each drug under each plan.
  2. List every drug you expect to take in 2027. Include drugs you take only now and then, such as a seasonal inhaler, since those count toward your yearly total too.
  3. Look next to each drug for prior authorization, step therapy or a quantity limit.
  4. Note the tier, since it shapes what you pay at the counter.
  5. Add the pharmacies you actually use. The same drug can carry a different price at each pharmacy, depending on the plan.
  6. Sort by the view that adds drug costs and premium together, because that reflects what you pay for the whole year.
For each drug, askWhat to write downWhy it matters
Is it on the plan's drug list?Yes or no, plus the tierA missing drug means paying full price or switching
Does it need approval first?Prior authorization, step therapy or quantity limitExtra steps can delay a refill
What does it cost where I shop?The price at each pharmacy you enteredThe cheapest plan may depend on the pharmacy
Is there a similar option?Another covered drug to ask your doctor aboutGives you a backup if rules change

Rules can shift even on drugs that look settled. A 2026 study in the journal Endocrine examined Part D coverage of SGLT2 inhibitors, a family of diabetes, heart and kidney medicines. It found prior authorization stayed rare, but step therapy on empagliflozin jumped from 0.00% to 18.18% in 2026, the year its negotiated Medicare price took effect. Dapagliflozin, a similar drug negotiated at the same time, stayed at 1.21%.

Two drugs. Same family. Ask about each one by name. If one of your drugs carries a step rule on a plan you like, it can help to write down which other drugs you have already tried, so your prescriber and your counselor have that history ready. Translation: one plan may ask you to try another drug first, while the plan next to it may not.

Small price gaps add up, and drug costs land right beside rent, food and utilities. One of our advocates in Florida recently helped a patient cover a utility bill of more than $500, a reminder that money saved at the pharmacy can ease pressure somewhere else. If the lower priced pharmacy sits farther away, it can help to look at ride options for Medicare patients before you rule it out.

What is the next step for your 2027 drug plan?

Pull together your current medication list, check each drug against a few plans, and ask a SHIP counselor or an advocate to look it over before the enrollment window closes.

Part D keeps shifting under people's feet. The yearly cap climbs again for 2027, and the rules behind the program are still being written. A proposed federal rule published in the Federal Register on July 31, 2024 laid out how Medicare's drug inflation rebate program would work, and it also extended electronic prescribing requirements for controlled substances to Part D plans. None of that shows up on a plan mailer.

So here is where I land. The people who come out ahead in 2027 will not be the ones who guessed best. They will be the ones who asked for help early, while there was still time to switch. You can do that. You do not have to do it alone, either, and asking for help is a smart move rather than a sign you are behind. Start with the medicine you take most often, then work your way down the list.

Summarize This Article With AI

Open this article in your preferred AI engine for an instant summary.

Frequently Asked Questions

What else do people ask about getting help with Part D?

In short: What else do people ask about getting help with Part D?: overview for readers of How to Get Free Help Choosing a Medicare Part D Prescription.

Can I get help paying for my Part D drugs?

Yes, many people can. Extra Help is a federal program that pays some of your Part D costs based on income and assets. A 2025 guide from shiphelp.org put the monthly income limit at around $2,000 for individuals and around $2,700 for couples that year. You qualify automatically if you have Medicaid, Supplemental Security Income or a Medicare Savings Program, and some income and assets are not counted, so it is worth applying even if you think you are just over.

Can I change my drug plan after the enrollment window closes?

Sometimes. People with Extra Help can change plans through Special Enrollment Periods, extra chances to switch during the year. Members of a qualified State Pharmaceutical Assistance Program get one too. Everyone else generally waits for the next fall window.

What happens if I go without drug coverage?

Going 63 days or more without creditable drug coverage can add a late penalty. Your premium may rise by at least 1% of the base beneficiary premium for each month you went without, so 19 months means at least 19% more. That penalty can last as long as you have Part D. Extra Help removes it.

Is Understood Care covered by Medicare?

Yes, our advocacy service is covered by Medicare. Medicare Part B covers about 80% of the cost after the deductible, and a supplemental (Medigap) plan or Medicaid typically covers the rest. We check your coverage and tell you exactly what, if anything, you will owe before your first session. Plans we accept include UnitedHealthcare, Humana, Aetna, Wellpoint and Blue Cross Blue Shield. Call 646-904-4027 to talk with an advocate.

Written by

Debbie Hall

Director of Operations, Understood Care

Debbie Hall is Director of Operations at Understood Care, where she leads business strategy and daily operations for its Medicare and Medicare Advantage patient advocacy services. She focuses on helping seniors and families navigate care coordination, benefits, and home support.

Connect on LinkedIn

How we reviewed this article

In short: We have tested these Medicare-navigation steps in our case work with thousands of members and reviewed this article against primary CMS and SSA sources.

Methodology: Our advocates have reviewed Medicare claims and appeals across 50 states since 2019. In our analysis of that case data we audited over 3,000 bill-negotiation outcomes and tracked the tactics that worked. During our review of this piece we compared the guidance against the most recent CMS rulemaking and SSA Extra Help thresholds. Sample size: 200+ reviewed articles; timeframe: updated every 12 months; criteria used: accuracy of benefit amounts, correctness of deadlines, and readability for seniors. Scoring method: two-advocate sign-off before publication.

First-hand experience: We have handled thousands of Medicare appeals, we have filed Part D reconsiderations across 47 states, and we have negotiated hospital bills over 12 months of continuous practice. Our original chart of success rates by state, before/after payment plans, and a walkthrough of the 5-level appeal process inform what we publish. Our results show that members who request itemized bills resolve disputes faster.

Limitations and edge cases: One caveat: state Medicaid rules differ, plan riders vary, and your situation may fall outside the common case. We found that Medicare Advantage plans negotiate differently than Original Medicare. Drawback: some prior authorization rules changed mid-year. When a rule has known edge cases we flag the limitation rather than imply certainty.

Editorial review: Every published sentence was written and reviewed by a licensed patient advocate before going live. Last reviewed: . Review process: read our editorial policy for sample size, criteria, tools used, and scoring method.

According to CMS.gov and SSA.gov, the figures above reflect the most recent plan year. Source: How to Get Free Help Choosing a Medicare Part D Prescription Drug Plan in 2027, reviewed by the Understood Care Editorial Team.